2025-02-122026-02-282026-02-28false16248850CROUCH END THERAPY LTD2026-10-07falseiso4217:GBPxbrli:pure162488502025-02-11162488502026-02-28162488502025-02-122026-02-28162488502025-02-10162488502025-02-11162488502025-02-112025-02-1116248850bus:SmallEntities2025-02-122026-02-2816248850bus:AuditExempt-NoAccountantsReport2025-02-122026-02-2816248850bus:AbridgedAccounts2025-02-122026-02-2816248850bus:PrivateLimitedCompanyLtd2025-02-122026-02-2816248850core:WithinOneYear2026-02-2816248850core:AfterOneYear2026-02-2816248850core:WithinOneYear2025-02-1116248850core:AfterOneYear2025-02-1116248850core:ShareCapital2026-02-2816248850core:SharePremium2026-02-2816248850core:RevaluationReserve2026-02-2816248850core:OtherReservesSubtotal2026-02-2816248850core:RetainedEarningsAccumulatedLosses2026-02-2816248850core:ShareCapital2025-02-1116248850core:SharePremium2025-02-1116248850core:RevaluationReserve2025-02-1116248850core:OtherReservesSubtotal2025-02-1116248850core:RetainedEarningsAccumulatedLosses2025-02-1116248850core:LandBuildings2026-02-2816248850core:PlantMachinery2026-02-2816248850core:Vehicles2026-02-2816248850core:FurnitureFittings2026-02-2816248850core:OfficeEquipment2026-02-2816248850core:NetGoodwill2026-02-2816248850core:IntangibleAssetsOtherThanGoodwill2026-02-2816248850core:ListedExchangeTraded2026-02-2816248850core:UnlistedNon-exchangeTraded2026-02-2816248850core:LandBuildings2025-02-1116248850core:PlantMachinery2025-02-1116248850core:Vehicles2025-02-1116248850core:FurnitureFittings2025-02-1116248850core:OfficeEquipment2025-02-1116248850core:NetGoodwill2025-02-1116248850core:IntangibleAssetsOtherThanGoodwill2025-02-1116248850core:ListedExchangeTraded2025-02-1116248850core:UnlistedNon-exchangeTraded2025-02-1116248850core:LandBuildings2025-02-122026-02-2816248850core:PlantMachinery2025-02-122026-02-2816248850core:Vehicles2025-02-122026-02-2816248850core:FurnitureFittings2025-02-122026-02-2816248850core:OfficeEquipment2025-02-122026-02-2816248850core:NetGoodwill2025-02-122026-02-2816248850core:IntangibleAssetsOtherThanGoodwill2025-02-122026-02-2816248850core:ListedExchangeTraded2025-02-122026-02-2816248850core:UnlistedNon-exchangeTraded2025-02-122026-02-2816248850core:MoreThanFiveYears2025-02-122026-02-2816248850core:Non-currentFinancialInstruments2026-02-2816248850core:Non-currentFinancialInstruments2025-02-1116248850dpl:CostSales2025-02-122026-02-2816248850dpl:DistributionCosts2025-02-122026-02-2816248850core:LandBuildings2025-02-122026-02-2816248850core:PlantMachinery2025-02-122026-02-2816248850core:Vehicles2025-02-122026-02-2816248850core:FurnitureFittings2025-02-122026-02-2816248850core:OfficeEquipment2025-02-122026-02-2816248850dpl:AdministrativeExpenses2025-02-122026-02-2816248850core:NetGoodwill2025-02-122026-02-2816248850core:IntangibleAssetsOtherThanGoodwill2025-02-122026-02-2816248850dpl:GroupUndertakings2025-02-122026-02-2816248850dpl:ParticipatingInterests2025-02-122026-02-2816248850dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-122026-02-2816248850core:ListedExchangeTraded2025-02-122026-02-2816248850dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-122026-02-2816248850core:UnlistedNon-exchangeTraded2025-02-122026-02-2816248850dpl:CostSales2025-02-112025-02-1116248850dpl:DistributionCosts2025-02-112025-02-1116248850core:LandBuildings2025-02-112025-02-1116248850core:PlantMachinery2025-02-112025-02-1116248850core:Vehicles2025-02-112025-02-1116248850core:FurnitureFittings2025-02-112025-02-1116248850core:OfficeEquipment2025-02-112025-02-1116248850dpl:AdministrativeExpenses2025-02-112025-02-1116248850core:NetGoodwill2025-02-112025-02-1116248850core:IntangibleAssetsOtherThanGoodwill2025-02-112025-02-1116248850dpl:GroupUndertakings2025-02-112025-02-1116248850dpl:ParticipatingInterests2025-02-112025-02-1116248850dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-112025-02-1116248850core:ListedExchangeTraded2025-02-112025-02-1116248850dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-112025-02-1116248850core:UnlistedNon-exchangeTraded2025-02-112025-02-1116248850core:NetGoodwill2026-02-2816248850core:IntangibleAssetsOtherThanGoodwill2026-02-2816248850core:LandBuildings2026-02-2816248850core:PlantMachinery2026-02-2816248850core:Vehicles2026-02-2816248850core:FurnitureFittings2026-02-2816248850core:OfficeEquipment2026-02-2816248850core:AfterOneYear2026-02-2816248850core:WithinOneYear2026-02-2816248850core:ListedExchangeTraded2026-02-2816248850core:UnlistedNon-exchangeTraded2026-02-2816248850core:ShareCapital2026-02-2816248850core:SharePremium2026-02-2816248850core:RevaluationReserve2026-02-2816248850core:OtherReservesSubtotal2026-02-2816248850core:RetainedEarningsAccumulatedLosses2026-02-2816248850core:NetGoodwill2025-02-1116248850core:IntangibleAssetsOtherThanGoodwill2025-02-1116248850core:LandBuildings2025-02-1116248850core:PlantMachinery2025-02-1116248850core:Vehicles2025-02-1116248850core:FurnitureFittings2025-02-1116248850core:OfficeEquipment2025-02-1116248850core:AfterOneYear2025-02-1116248850core:WithinOneYear2025-02-1116248850core:ListedExchangeTraded2025-02-1116248850core:UnlistedNon-exchangeTraded2025-02-1116248850core:ShareCapital2025-02-1116248850core:SharePremium2025-02-1116248850core:RevaluationReserve2025-02-1116248850core:OtherReservesSubtotal2025-02-1116248850core:RetainedEarningsAccumulatedLosses2025-02-1116248850core:NetGoodwill2025-02-1016248850core:IntangibleAssetsOtherThanGoodwill2025-02-1016248850core:LandBuildings2025-02-1016248850core:PlantMachinery2025-02-1016248850core:Vehicles2025-02-1016248850core:FurnitureFittings2025-02-1016248850core:OfficeEquipment2025-02-1016248850core:AfterOneYear2025-02-1016248850core:WithinOneYear2025-02-1016248850core:ListedExchangeTraded2025-02-1016248850core:UnlistedNon-exchangeTraded2025-02-1016248850core:ShareCapital2025-02-1016248850core:SharePremium2025-02-1016248850core:RevaluationReserve2025-02-1016248850core:OtherReservesSubtotal2025-02-1016248850core:RetainedEarningsAccumulatedLosses2025-02-1016248850core:AfterOneYear2025-02-122026-02-2816248850core:WithinOneYear2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:CostValuation2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-122026-02-2816248850core:Non-currentFinancialInstrumentscore:CostValuation2026-02-2816248850core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-02-2816248850core:Non-currentFinancialInstrumentscore:CostValuation2025-02-1116248850core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-1116248850core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-1116248850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-1116248850core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-1116248850core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-1116248850core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-1116248850core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-1116248850core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-1116248850bus:Director12025-02-122026-02-28

CROUCH END THERAPY LTD

Registered Number
16248850
(England and Wales)

Unaudited Financial Statements for the Period ended
28 February 2026

CROUCH END THERAPY LTD
Company Information
for the period from 12 February 2025 to 28 February 2026

Director

OZANNE, Colin Nathanael

Registered Address

46 Marlborough Road
London
N22 8NN

Registered Number

16248850 (England and Wales)
CROUCH END THERAPY LTD
Statement of Financial Position
28 February 2026

Notes

2026

£

£

Fixed assets
Tangible assets36,576
6,576
Current assets
Debtors45,032
Cash at bank and on hand1,119
6,151
Creditors amounts falling due within one year5(30,687)
Net current assets (liabilities)(24,536)
Total assets less current liabilities(17,960)
Net assets(17,960)
Capital and reserves
Called up share capital1
Profit and loss account(17,961)
Shareholders' funds(17,960)
The financial statements were approved and authorised for issue by the Director on 7 October 2026, and are signed on its behalf by:
OZANNE, Colin Nathanael
Director
Registered Company No. 16248850
CROUCH END THERAPY LTD
Notes to the Financial Statements
for the period ended 28 February 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings15
Office Equipment25
2.Average number of employees

2026
Average number of employees during the year0
3.Tangible fixed assets

Total

£
Cost or valuation
Additions7,514
At 28 February 267,514
Depreciation and impairment
Charge for year938
At 28 February 26938
Net book value
At 28 February 266,576
At 11 February 25-
4.Debtors: amounts due within one year

2026

£
Trade debtors / trade receivables217
Other debtors4,815
Total5,032
5.Creditors: amounts due within one year

2026

£
Other creditors30,437
Accrued liabilities and deferred income250
Total30,687